Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

FACT- Frankfurt Adjusted COVID-19 Testing- a Novel Method Enables High-throughput SARS-CoV-2 Screening Without Loss of Sensitivity
  • Language: en

FACT- Frankfurt Adjusted COVID-19 Testing- a Novel Method Enables High-throughput SARS-CoV-2 Screening Without Loss of Sensitivity

  • Type: Book
  • -
  • Published: 2020
  • -
  • Publisher: Unknown

Background In the pandemic, testing for SARS-CoV-2 by RT-PCR in one of the pillars on which countermeasures are based. Factors limiting the output of laboratories interfere with the effectiveness of public health measures. Conserving reagents by pooling samples in low-probability settings is proposed, but may cause dilution and loss of sensitivity. Methods We tested an alternate approach (FACT) by simultaneously incubating multiple respiratory swabs in a single tube. This protocol was evaluated by serial incubation of a respiratory swab in up to 10 tubes. The analytics validity of this concept was demonstrated in a five-sample mini pool set-up. It was consequently applied in the testing of 5...

Novel Multiple Swab Method Enables High Efficiency in SARS-CoV-2 Screenings Without Loss of Sensitivity for Screening of a Complete Population
  • Language: en

Novel Multiple Swab Method Enables High Efficiency in SARS-CoV-2 Screenings Without Loss of Sensitivity for Screening of a Complete Population

  • Type: Book
  • -
  • Published: 2020
  • -
  • Publisher: Unknown

Background: In the pandemic, testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time polymerase chain reaction is one of the pillars on which countermeasures are based. Factors limiting the output of laboratories interfere with the effectiveness of public health measures. Conserving reagents by pooling samples in low-probability settings is proposed but may cause dilution and loss of sensitivity. Blood transfusion services had experience in performance of high throughput nucleic acid testing (NAT) analysis and can support the national health system by screening of the inhabitants for SARS-COV-2. Methods: We evaluated a new approach of a multiple-swab method by s...

Coronavirus Disease - COVID-19
  • Language: en
  • Pages: 964

Coronavirus Disease - COVID-19

In December 2019, the world witnessed the occurrence of a new coronavirus to humanity. The disease spread quickly and became known as a pandemic globally, affecting both society and the health care system, both the elderly and young groups of people, and both the men’s and women’s groups. It was a universal challenge that immediately caused a surge in scientific research. Be a part of a world rising in fighting against the pandemic, the Coronavirus Disease - COVID-19 was depicted in the early days of the pandemic, but updated by more than 200 scientists and clinicians to include many facets of this new infectious pandemic, including i, characteristics, ecology, and evolution of coronavir...

Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies
  • Language: en

Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies

  • Type: Book
  • -
  • Published: 2021
  • -
  • Publisher: Unknown

Due to numerous mutations in the spike protein, the SARS-CoV-2 variant of concern Omicron (B.1.1.529) raises serious concerns since it may significantly limit the antibody-mediated neutralization and increase the risk of reinfections. While a rapid increase in the number of cases is being reported worldwide, until now there has been uncertainty about the efficacy of vaccinations and monoclonal antibodies. Our in vitro findings using authentic SARS-CoV-2 variants indicate that in contrast to the currently circulating Delta variant, the neutralization efficacy of vaccine-elicited sera against Omicron was severely reduced highlighting T-cell mediated immunity as essential barrier to prevent severe COVID-19. Since SARS-CoV-2 Omicron was resistant to casirivimab and imdevimab, genotyping of SARS-CoV-2 may be needed before initiating mAb treatment. Variant-specific vaccines and mAb agents may be required to treat COVID-19 due to Omicron and other emerging variants of concern.

Official Summary of Stock Transactions and Holdings of Officiers, Directors, and Principal Stockholders
  • Language: en
  • Pages: 208
MEDINFO 2023 — The Future Is Accessible
  • Language: en
  • Pages: 1676

MEDINFO 2023 — The Future Is Accessible

  • Type: Book
  • -
  • Published: 2024-04-02
  • -
  • Publisher: IOS Press

Science-fiction author William Gibson is famously quoted as saying, “The future is already here – it's just not very evenly distributed.” During the Covid pandemic, telehealth and remote monitoring were elevated from interesting innovations to essential tools in many healthcare systems, but not all countries had the infrastructure necessary to pivot quickly, amply demonstrating the negative consequences of the digital divide. This book presents the proceedings of MedInfo 2023, the 19th World Congress on Medical and Health Informatics, held from 8 – 12 July 2023 in Sydney, Australia. This series of biennial conferences provides a platform for the discussion of applied approaches to da...

Catalogue
  • Language: en
  • Pages: 516

Catalogue

  • Type: Book
  • -
  • Published: 1926
  • -
  • Publisher: Unknown

None

Poor's
  • Language: en
  • Pages: 3338

Poor's

  • Type: Book
  • -
  • Published: 1935
  • -
  • Publisher: Unknown

None